Nikhil Rao and Alek Petuskey are building Pynecone, an open-source framework to build web apps in pure Python and deploy with a single command. See their Launch HN post.
![]() | ![]() |
---|
Zach Tratar is building Embra, the fastest GPT assistant for your professional life.
![]() |
---|
Banks Hunter and Max Justicz are building Charge: robots that automate the most labor-intensive parts of building large-scale solar farms. See their Launch HN post.
![]() | ![]() |
---|
Opendoor veterans Justine Palefsky and Tasneem Amina are building Kindred, a members-only network for home-sharing that provides a new model for travel. Read about their launch in Forbes and TechCrunch.
![]() | ![]() |
---|
Michelle Lee, PhD, turned down a tenure-track professor position at NYU to build Medra, where she's applying robotics, computer vision, and AI to biotech manufacturing.
![]() |
---|
Erik Dunteman and Kyle Morris are building Banana, a serverless hosting platform for AI/ML, providing effortless access to GPUs to companies building on top of AI.
![]() | ![]() |
---|
Regulatory experts Niya Dragova and David Chouinard are building Candor, a platform enabling public company employees to manage RSUs like executives.
Listen to Niya sharing her story on Indie Hackers.
![]() | ![]() |
---|
Michael Fester and Marie Schneegans are building Motif, which combines the simplicity and collaboration of Google Docs with the power of fully interactive React websites.
![]() | ![]() |
---|
Olly Wilson and Alex Kilkka are building SimpleHash, which provides infrastructure for multi-chain NFT indexing and querying.
![]() | ![]() |
---|
Patricia Bubner, PhD, Gabriel Levesque-Tremblay, PhD, and Samet Yildirim are building Orbillion, the only lab-grown meat company making high-end meats including lamb, elk, and bison.
See coverage of Orbillion in TechCrunch here and here.
![]() | ![]() | ![]() |
---|
David Li, Joan Smith, and Jason Sheltzer, PhD are building Meliora, a computational platform to identify the true mechanism of action (MOAs) for oncology drugs at scale.
See coverage of Meliora Therapeutics in The Wall Street Journal here.
![]() | ![]() | ![]() |
---|